Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Research-based pharmaceutical company publishes annual report for 2004
April 7th, 2005
Schering AGSHR published its Group Annual Report and Accounts for 2004 on the occasion of its Annual Press Conference. Schering reported net sales of EUR 4.9 billion ($6.5 billion) in business year 2004. At EUR 761 million, operating profit was up 11% on the previous year's figure. Net profit rose from EUR 443 million ($590 million) in 2003 to EUR 500 million ($665.9 million) in 2004, a 13% increase year-on-year. Earnings per share were up by 14% to EUR 2.61 ($3.5) compared to EUR 2.28 ($3.0) in 2003. Particularly due to the success of the oral contraceptive Yasmin (net sales +56% currency adjusted), Schering became the world leader in fertility...
Source: Women's Health Weekly (2005-04-07)
|
